Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases

Liver diseases caused by viral infection, alcohol abuse and metabolic disorders can progress to end‐stage liver failure, liver cirrhosis and liver cancer, which are a growing cause of death worldwide. Although liver transplantation and hepatocyte transplantation are useful strategies to promote live...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of cellular and molecular medicine Ročník 24; číslo 1; s. 40 - 49
Hlavní autori:	Hu, Chenxia, Wu, Zhongwen, Li, Lanjuan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England John Wiley & Sons, Inc 01.01.2020 John Wiley and Sons Inc
Predmet:	Abuse Alcohol abuse Analgesics Animals Anoikis Anti-Inflammatory Agents - pharmacology Apoptosis Bile Cell culture Cell Differentiation Cell Hypoxia Cell therapy Cirrhosis Collagen Cytokeratin Cytokines Drug abuse Fibroblasts gene modification Growth factors Hepatitis Hepatocytes Humans Hypoxia Immunomodulation Immunomodulators Inflammation Kinases Liver cancer Liver cirrhosis liver disease Liver diseases Liver Diseases - pathology Liver Diseases - therapy Liver failure Liver Regeneration Liver transplantation Medical prognosis mesenchymal stem cell Mesenchymal Stem Cell Transplantation - methods Mesenchymal stem cells Mesenchymal Stem Cells - cytology Mesenchymal Stem Cells - drug effects Mesenchyme Metabolic disorders Metabolism Metastasis Microenvironments Oxidative stress Paracrine signalling pre‐treatment Proteins Review Reviews Stem cells Surgical outcomes survival Transplantation Conditioning Tumor necrosis factor-TNF gene modification mesenchymal stem cell liver disease pre-treatment survival
ISSN:	1582-1838, 1582-4934, 1582-4934
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!